Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-26Clinical Trial Update: Linkage to Care and Treatment of Chronic HBV Patients [NA]
This completed clinical trial from The University of Hong Kong evaluated linkage to care and treatment among patients with chronic hepatitis…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients [Phase 4]
The clinical trial update states that the Phase 4 study of DA-2803 in chronic hepatitis B has completed. No efficacy or safety results are d…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: A Study to Evaluate the Antiviral Activity and Safety of HH-003 in Chronic Hepatitis B Subjects With Low-level Viremia [Phase 2]
Phase 2 trial evaluating antiviral activity and safety of HH-003 in adults with chronic hepatitis B infection and low-level viremia has comp…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: A Study of LW231 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection [Phase 1]
A Phase 1 trial evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of LW231 in healthy volunteers and participants with…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis [Phase 1, Phase 2]
Completed Phase 1/2 clinical trial evaluating the safety and effectiveness of PRI-724 in patients with cirrhosis due to Hepatitis C or Hepat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: Effectiveness of Antiviral Treatment in Cirrhotic Patients with Low-level Hepatitis B Virus DNA Levels [Phase 4]
A Phase 4 clinical trial is evaluating the effectiveness of antiviral treatment in patients with chronic hepatitis B–related cirrhosis who h…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Study of VIR-3434 in Healthy Volunteers and Patients With Chronic Hepatitis B Virus Infection [Phase 1]
Phase 1 trial update for VIR-3434 in healthy volunteers and patients with chronic hepatitis B; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection
This update reports the completed status of a long-term clinical trial evaluating liver disease in people with hepatitis B and/or hepatitis …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Study of JNJ-73763989, Pegylated Interferon Alpha-2a, Nucleos(t)Ide Analog (NA) With or Without JNJ-56136379 in Treatment-naive Participants With Hepatitis B e Antigen (HBeAg) Positive Chronic Hepatitis B Virus (HBV) Infection [Phase 2]
Phase 2 study evaluating JNJ-73763989 with pegylated interferon alpha-2a, and a nucleos(t)ide analog, with or without JNJ-56136379, in treat…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Study of Safety and Tolerability of DCR HBVS [Phase 1]
Phase 1 study of DCR HBVS in chronic hepatitis B has completed, with safety and tolerability data reported.
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: The Effects of Vitamin D and Calcium Supplementation to Parathyroid Hormone in CHB Patients Treated With TDF [Phase 4]
A Phase 4 clinical trial evaluating whether vitamin D and calcium supplementation modulates parathyroid hormone in patients with chronic hep…
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: Liver Status and Presence of MASLD/MASH in Patients With Chronic Hepatitis B
This clinical trial update notes the completed study investigating liver status and the presence of MASLD/MASH in patients with chronic hepa…
-
CLINICAL_TRIALS trial_result · 2024-08-26Clinical Trial Update: Study of VIR-2218 in Patients With Chronic Hepatitis B in Mainland China [Phase 2]
A Phase 2 study of VIR-2218 for chronic hepatitis B in Mainland China has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-08-13Clinical Trial Update: First-In-Human Study of ChAdOx1-HBV & MVA-HBV Vaccines (VTP-300) for Chronic HBV [Phase 1, Phase 2]
A first-in-human study of ChAdOx1-HBV and MVA-HBV vaccines (VTP-300) for chronic hepatitis B completed Phase 1/2, with results posted in Aug…
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Efficacy and Safety Study of Peginterferon Alfacon-2 to Treat Chronic Hepatitis B Virus Infection [Phase 3]
The document provides an update on the efficacy and safety of Peginterferon Alfacon-2 in a Phase 3 study for chronic hepatitis B, which has …
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection [Phase 2]
Phase 2 trial evaluating the combination of JNJ-73763989 and JNJ-56136379 with a nucleos(t)ide analog versus a nucleos(t)ide analog alone in…
-
CLINICAL_TRIALS trial_result · 2024-07-24Clinical Trial Update: Study on New Strategies for Hepatitis B Virus Immunization [NA]
This clinical trial update notes completion of a study exploring new strategies for Hepatitis B vaccination.
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: A Clinical Study of 162 in Subjects With Chronic Hepatitis B Virus Infection [Phase 1]
Phase 1 trial (NCT06159062) of 162 participants with chronic hepatitis B infection sponsored by Yangshengtang Co., Ltd was terminated.
-
CLINICAL_TRIALS trial_result · 2024-07-15Clinical Trial Update: A Study of Hepalatide Combined With TAF and PEG-IFN as Finite Treatment of Chronic Hepatitis B Patients [Phase 2]
Phase 2 clinical trial evaluating Hepalatide in combination with TAF and PEG-IFN as a finite treatment for chronic hepatitis B has completed…
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus Infection [Phase 2]
Phase 2 trial evaluating combination regimens including JNJ-73763989 and JNJ-56136379 for chronic hepatitis B; the study is completed and re…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: A Study of JNJ-73763989, JNJ-56136379, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection [Phase 2]
Phase 2 study evaluating two Janssen investigational agents (JNJ-73763989 and JNJ-56136379) in virologically suppressed adults with chronic …
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: HepB-CpG Series for Healthcare Workers Who Are Hepatitis B Vaccine Nonresponders [Phase 4]
Phase 4 clinical trial update on the HepB-CpG vaccine series for healthcare workers who did not respond to hepatitis B vaccination; results …
-
CLINICAL_TRIALS trial_result · 2024-06-21Clinical Trial Update: Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection [Phase 2]
Phase 2 trial evaluating GLS4 in combination with ritonavir for chronic hepatitis B infection has been completed, assessing safety, tolerabi…
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic Hepatitis B Virus (HBV) Infection [Phase 2]
This clinical trial update reports a Phase 2 study by Brii Biosciences evaluating the safety and efficacy of BRII-835 and BRII-179 combinati…
-
CLINICAL_TRIALS trial_result · 2024-06-04Clinical Trial Update: Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV) [Phase 1, Phase 2]
Phase 1/2 study update of ARO-HBV in healthy volunteers and patients with Hepatitis B, with results posted in June 2024.